Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Benchmark: Surging Copper Prices Highlight Looming Global Supply Challenges March 11, 2026 Canada’s Junior Miners Still in Challenging Financial Climate as Metals Prices Climb March 11, 2026 Silver Stocks: 5 Biggest Silver-mining Companies in 2026 March 11, 2026